Rocket Net Tangible Assets from 2010 to 2024

RCKT Stock  USD 14.10  0.01  0.07%   
Rocket Pharmaceuticals Net Tangible Assets yearly trend continues to be comparatively stable with very little volatility. Net Tangible Assets will likely drop to about 252.1 M in 2024. Net Tangible Assets is the total assets of Rocket Pharmaceuticals minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2015-03-31
Previous Quarter
394 M
Current Value
338.1 M
Quarterly Volatility
151.8 M
 
Yuan Drop
 
Covid
Check Rocket Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rocket Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.5 M, Interest Expense of 3.3 M or Selling General Administrative of 77 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.37. Rocket financial statements analysis is a perfect complement when working with Rocket Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Rocket Pharmaceuticals Correlation against competitors.
For more information on how to buy Rocket Stock please use our How to Invest in Rocket Pharmaceuticals guide.

Latest Rocket Pharmaceuticals' Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Rocket Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Rocket Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rocket Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Slightly volatile
   Net Tangible Assets   
       Timeline  

Rocket Net Tangible Assets Regression Statistics

Arithmetic Mean173,139,317
Coefficient Of Variation125.24
Mean Deviation188,421,938
Median108,813,000
Standard Deviation216,841,648
Sample Variance47020.3T
Range555.1M
R-Value0.88
Mean Square Error11361.8T
R-Squared0.78
Significance0.000015
Slope42,702,507
Total Sum of Squares658284.2T

Rocket Net Tangible Assets History

2024252.1 M
2023488.5 M
2022424.8 M
2021454.8 M
2020503.5 M
2019307.3 M
2018194 M

About Rocket Pharmaceuticals Financial Statements

Rocket Pharmaceuticals shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Rocket Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Rocket Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Rocket Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Tangible Assets488.5 M252.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rocket Stock Analysis

When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.